Royalty Pharma (RPRX) Stock Price & Financial Analysis
Royalty Pharma Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Royalty Pharma
What is the current stock price for RPRX?
As of the latest trading session, RPRX stock trades at $53.57. The 52-week range is $34.08–$56.50, with a day range of $52.89–$53.71.
What is the P/E ratio for RPRX?
Royalty Pharma's trailing P/E ratio is 36.2, meaning investors pay $36.2 for every $1 of annual earnings. The forward P/E is 45.0, reflecting analyst expectations for future earnings. Royalty Pharma operates in the Healthcare sector.
Does RPRX pay dividends?
Yes, Royalty Pharma pays a 1.70% annual dividend yield ($0.91 per share). The payout ratio is 57.9%. The last ex-dividend date was 2026-05-15.
What do analysts recommend for RPRX?
Based on 7 analysts, the consensus for RPRX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of RPRX?
Royalty Pharma's market capitalization is $29.98B, classifying it as a large-cap company. Royalty Pharma operates in the Healthcare sector within the Biotechnology industry.